Click below for our latest newsletter.

   

CFOAward09 web.jpg (44501 bytes)


Start-up Australia is a specialist venture capital company which invests in innovative life science companies which have high growth prospects. These companies may operate in a range of sectors including; human health, animal health, agritech and  environmental technology. As our portfolio companies have grown in value, we have been able to deliver attractive financial returns to our investors.

 

Click here if you would like to subscribe to our quarterly newsletter.

 

Latest News

Positive new data on BNC210 presented at conference. 

BNC105 commences US clinical trials in renal cancer. 

Start-up Australia wins "Private Equity Exit of the Year".

First stage of BNC210 clinical trial successfully completed.

New data on anxiety drug to be presented at international conference.

Bionomics $15 million capital raising.

Start-up Australia Ventures Pty Ltd Placement in Bionomics.

Bionomics to undertake US clinical trial on BNC210 in renal cell cancer.

Phase I clinical trial on Bionomics' anti-anxiety drug BNC210 initiated.

Initial Phase I data on cancer drug presented.

Anti-anxiety drug approved to enter human clinical trials.

Cephalon offer for Arana goes unconditional.

Fondaparinux ANDA accepted by FDA for review

Bionomics: New data on BNC105 presented to AACR.

Alchemia and SDP Technology enter cancer drug collaboration.

Alchemia announces filing of Abbreviated New Drug Application to FDA for fondaparinux.